Form 4 for ELF e.l.f. Beauty, Inc.
Accepted 2026-04-02 16:04:45 ET · period of report 2026-04-01 · accession 0001610717-26-000139 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-04-02 16:04 | 2026-04-01 | ELF | AMIN TARANG | CEO, Dir | M - OptEx | $26.84 | +71.0K | 151.3K | +88% | +$1.91M |
| DMT | 2026-04-02 16:04 | 2026-04-01 | ELF | AMIN TARANG | CEO, Dir | S - Sale+OE | $62.64 | -52.9K | 98.4K | -35% | -$3.31M |
| DT | 2026-04-02 16:04 | 2026-04-01 | ELF | AMIN TARANG | CEO, Dir | M - OptEx | $0.00 | -71.0K | 142.0K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.01 par value | 2026-04-01 | M | A | 71,000 | $26.84 | 151,296 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025. The sales reported herein were made solely to cover tax liabilities in connection with the exercise of stock options. The Reporting Person otherwise retained the remaining shares from the exercise. (F2) Includes 80,255 restricted stock units. |
| 2 | Common | Common Stock, $0.01 par value | 2026-04-01 | S | D | 31,630 | $62.44 | 119,666 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025. The sales reported herein were made solely to cover tax liabilities in connection with the exercise of stock options. The Reporting Person otherwise retained the remaining shares from the exercise. (F3) The transaction was executed in multiple trades in prices ranging from $61.75 to $62.74, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. (F2) Includes 80,255 restricted stock units. |
| 3 | Common | Common Stock, $0.01 par value | 2026-04-01 | S | D | 21,250 | $62.93 | 98,416 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025. The sales reported herein were made solely to cover tax liabilities in connection with the exercise of stock options. The Reporting Person otherwise retained the remaining shares from the exercise. (F4) The transaction was executed in multiple trades in prices ranging from $62.75 to $63.53, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. (F2) Includes 80,255 restricted stock units. |
| 4 | Derivative | Stock Option (Right to Buy) | 2026-04-01 | M | D | 71,000 | $0.00 | 142,000 | D | $26.84 · — to 2027-02-14 | 71,000 Common Stock | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025. The sales reported herein were made solely to cover tax liabilities in connection with the exercise of stock options. The Reporting Person otherwise retained the remaining shares from the exercise. (F5) Fully vested and exercisable. |